Karthik Nagaraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Karthik Nagaraj has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alicia Gonzalez-Martinez
Facultad de Medicina, Universidad Autónoma de Madrid (UAM), Madrid Spain
1 shared publication - Diana Yi-Ting Wei
Headache Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
1 shared publication - Helin Gosalia
King's College London
1 shared publication - Nazia Karsan
King's College London
1 shared publication - Peter James Goadsby
King Abdullah University of Science and Technology
1 shared publication
Latest Publications
- Open Access
- 29 April 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (4)
Evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine
Background: Our knowledge of the presence and type of premonitory symptoms in patients with cluster headache is limited. Methods: Premonitory symptom presence and type in a clinical cohort of cluster headache and migraine was collated retrospectively from clinical notes, alongside a cluster headache nitroglycerin triggered experimental group and an age-matched migraine nitroglycerin experimental group. Demographic data and premonitory symptoms in cluster headache and migraine patients were analysed. The primary focus was on premonitory symptom presence and phenotype in cluster headache patients, with secondary analysis exploring associated factors and comparing spontaneous and nitroglycerin-triggered symptoms in cluster headache and migraine cohorts. Results: Among 164 cluster headache patients, 122/164 (74%) males, aged 45.9 ± 13.8 years (mean ± SD), 66/164 (40%) had chronic cluster headache and 32/164 (20%) had also comorbid migraine. Among them, 85% exhibited premonitory symptoms for which the presence was associated with oxygen treatment. No significant differences were found in symptom frequency between cluster headache and migraine cohorts or within spontaneous and nitroglycerin-triggered symptoms. Conclusions: This study highlights recognizable spontaneous and nitroglycerin-triggered premonitory symptoms in cluster headache and factors potentially impacting cluster headache management, which may aid in tailoring treatment strategies for both conditions through the use of treatment prediction and early intervention.
- 29 April 2025
- Published by SAGE Publications in Cephalalgia
- Vol. 45 (4)
Open AccessEvaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine
Background: Our knowledge of the presence and type of premonitory symptoms in patients with cluster headache is limited. Methods: Premonitory symptom presence and type in a clinical cohort of cluster headache and migraine was collated retrospectively from clinical notes, alongside a cluster headache nitroglycerin triggered experimental group and an age-matched migraine nitroglycerin experimental group. Demographic data and premonitory symptoms in cluster headache and migraine patients were analysed. The primary focus was on premonitory symptom presence and phenotype in cluster headache patients, with secondary analysis exploring associated factors and comparing spontaneous and nitroglycerin-triggered symptoms in cluster headache and migraine cohorts. Results: Among 164 cluster headache patients, 122/164 (74%) males, aged 45.9 ± 13.8 years (mean ± SD), 66/164 (40%) had chronic cluster headache and 32/164 (20%) had also comorbid migraine. Among them, 85% exhibited premonitory symptoms for which the presence was associated with oxygen treatment. No significant differences were found in symptom frequency between cluster headache and migraine cohorts or within spontaneous and nitroglycerin-triggered symptoms. Conclusions: This study highlights recognizable spontaneous and nitroglycerin-triggered premonitory symptoms in cluster headache and factors potentially impacting cluster headache management, which may aid in tailoring treatment strategies for both conditions through the use of treatment prediction and early intervention.